ARDX was reiterated as Buy by HC Wainwright, and the target price was raised to US$10. The valuation is seriously undervalued. Performance growth, capital investment, full momentum, and surge is imminent.

: Professor Mike shared it around 5.6 last Friday, and he really predicted that market funds would flow back into the medical sector in the near future. That’s amazing. If small and medium-sized technology stocks such as biomedicine and healthcare fall sharply, they will rise. However, today’s HUT and SOUN still have to observe the market of Bitcoin and Nvidia, the AI leader.